Agilent Technologies this week rolled out its SurePrint G3 microarray platform, which contains up to one million probes on a standard 1x3 inch glass slide — up from 244,000 probes on the last version of its chips.

Initial applications available in the G3 format are for comparative genomic hybridization and copy number variation, but Agilent has pledged that all of its array-based applications — which include gene expression, microRNA expression, methylation, chromatin immunoprecipitation, and others — will eventually be available on the higher-density chips.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.